View in EDS

Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?

Saved in:
Bibliographic Details
Title: Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?
Authors: Arrivé C; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital, Grenoble, France. carrive1@chu-grenoble.fr.; Univ. Grenoble Alpes, HP2 INSERM U1300, 38041, Grenoble, France. carrive1@chu-grenoble.fr., Hotot M; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital, Grenoble, France., Jourdil JF; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital, Grenoble, France., Stanke-Labesque F; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, HP2 INSERM U1300, 38041, Grenoble, France.
Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2026 Jul; Vol. 40 (4), pp. 693-712. Date of Electronic Publication: 2026 Jun 12.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42283936
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Arrivé+C%22">Arrivé C</searchLink>; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital, Grenoble, France. carrive1@chu-grenoble.fr.; Univ. Grenoble Alpes, HP2 INSERM U1300, 38041, Grenoble, France. carrive1@chu-grenoble.fr.<br /><searchLink fieldCode="AU" term="%22Hotot+M%22">Hotot M</searchLink>; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Jourdil+JF%22">Jourdil JF</searchLink>; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Stanke-Labesque+F%22">Stanke-Labesque F</searchLink>; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, HP2 INSERM U1300, 38041, Grenoble, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229705305%22">BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</searchLink> [BioDrugs] 2026 Jul; Vol. 40 (4), pp. 693-712. <i>Date of Electronic Publication: </i>2026 Jun 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9705305 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-190X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211738804%22">11738804 </searchLink><i>NLM ISO Abbreviation: </i>BioDrugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42283936
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40259-026-00790-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 693
    Titles:
      – TitleFull: Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Arrivé C
      – PersonEntity:
          Name:
            NameFull: Hotot M
      – PersonEntity:
          Name:
            NameFull: Jourdil JF
      – PersonEntity:
          Name:
            NameFull: Stanke-Labesque F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-190X
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
              Type: main
ResultId 1